We are live on ! Find out more
Nuveen

Nuveen Portfolio holdings

AUM $419B
1-Year Est. Return 43.02%
This Fund
S&P 500
This Quarter Est. Return
+26.22%
1 Year Est. Return
+43.02%
3 Year Est. Return
+139.43%
5 Year Est. Return
+185.66%
10 Year Est. Return
+615.13%
AUM
$246B
AUM Growth
+$40.4B
Cap. Flow
-$4.05B
Cap. Flow %
-1.65%
Top 10 Hldgs %
22.52%
Holding
3,466
New
266
Increased
1,402
Reduced
1,481
Closed
200

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$613M
2
MTCH icon
Match Group
MTCH
+$518M
3
META icon
Meta Platforms (Facebook)
META
+$508M
4
RTX icon
RTX Corp
RTX
+$456M
5
LLY icon
Eli Lilly
LLY
+$364M

Top Sells

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$828M
2
MSFT icon
Microsoft
MSFT
+$510M
3
GILD icon
Gilead Sciences
GILD
+$465M
4
MRK icon
Merck
MRK
+$376M
5
WMT icon
Walmart Inc
WMT
+$369M

Sector Composition

Rank Sector Weight
1 Technology 23.85%
2 Healthcare 14.27%
3 Financials 12.45%
4 Consumer Discretionary 12.22%
5 Communication Services 9.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MDLZ icon
76
Mondelez International
MDLZ
$76.6B
$656M 0.27%
12,829,160
-1,968,578
-13% -$101M
TJX icon
77
TJX Companies
TJX
$143B
$643M 0.26%
12,724,168
+2,127,645
+20% +$107M
BA icon
78
Boeing
BA
$157B
$640M 0.26%
3,493,913
+267,900
+8% +$41.2M
DHR icon
79
Danaher
DHR
$158B
$635M 0.26%
4,049,213
-344,892
-8% -$49.5M
CB icon
80
Chubb
CB
$129B
$633M 0.26%
5,001,648
+465,487
+10% +$53.9M
TMUS icon
81
T-Mobile US
TMUS
$178B
$633M 0.26%
6,076,147
+3,702,833
+156% +$355M
CCI icon
82
Crown Castle
CCI
$28.8B
$623M 0.25%
3,723,982
+8,315
+0.2% +$1.34M
LRCX icon
83
Lam Research
LRCX
$393B
$618M 0.25%
19,102,320
-2,021,440
-10% -$55.1M
MDT icon
84
Medtronic
MDT
$113B
$612M 0.25%
6,671,752
-333,952
-5% -$32M
AMD icon
85
Advanced Micro Devices
AMD
$1.03T
$607M 0.25%
11,532,429
+841,525
+8% +$44.6M
SBUX icon
86
Starbucks
SBUX
$107B
$603M 0.25%
8,191,343
+1,496,845
+22% +$112M
MRSH
87
Marsh
MRSH
$82B
$602M 0.25%
5,610,220
-252,636
-4% -$25.6M
CVS icon
88
CVS Health
CVS
$114B
$597M 0.24%
9,196,421
-1,440,977
-14% -$90.7M
ELV icon
89
Elevance Health
ELV
$86.3B
$597M 0.24%
2,271,105
-58,304
-3% -$15.6M
LMT icon
90
Lockheed Martin
LMT
$119B
$574M 0.23%
1,573,706
-76,382
-5% -$28.9M
DD icon
91
DuPont de Nemours
DD
$17.8B
$572M 0.23%
8,576,999
+2,424,379
+39% +$142M
ROP icon
92
Roper Technologies
ROP
$35.5B
$562M 0.23%
1,446,757
-298,534
-17% -$107M
TGT icon
93
Target
TGT
$71.3B
$519M 0.21%
4,323,857
-1,016,888
-19% -$116M
MNST icon
94
Monster Beverage
MNST
$84.1B
$502M 0.2%
28,978,796
-10,458,652
-27% -$171M
ZBH icon
95
Zimmer Biomet
ZBH
$17.4B
$490M 0.2%
4,230,913
+291,247
+7% +$33.6M
GILD icon
96
Gilead Sciences
GILD
$186B
$490M 0.2%
6,371,731
-6,067,783
-49% -$465M
HUM icon
97
Humana
HUM
$48.3B
$482M 0.2%
1,243,462
-62,333
-5% -$23.3M
AEP icon
98
American Electric Power
AEP
$64.1B
$475M 0.19%
5,958,813
-511,518
-8% -$41.8M
UBER icon
99
Uber
UBER
$142B
$474M 0.19%
15,238,744
+5,369,305
+54% +$167M
CMG icon
100
Chipotle Mexican Grill
CMG
$39.7B
$472M 0.19%
22,432,050
-2,876,400
-11% -$53.3M

Similar funds

Nuveen's Q2 2020 Portfolio in Review

As of Q2 2020, Nuveen held 3,466 positions worth $246B, up 20% from $205B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Nuveen's Q2 2020 filing shows 266 new, 1,402 increased, 1,481 reduced and 200 closed positions. Its largest new stake was Zoom: 841,153 shares worth $213M. The largest sale was Amazon, an estimated $828M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Nuveen's largest Q2 2020 buy was Zoom: 841,153 shares worth $213M.
  • Nuveen added most to AbbVie in Q2 2020, an estimated $613M increase.
  • Nuveen's biggest Q2 2020 reduction was Amazon, cutting an estimated $828M.
  • Nuveen fully exited Allergan plc in Q2 2020, selling an estimated $212M.
  • Nuveen's ten largest holdings make up 23% of its $246B portfolio in Q2 2020.
  • Nuveen opened 266 new positions and closed 200 in Q2 2020.
  • Nuveen's portfolio value rose 20% quarter-over-quarter to $246B.

Based on Nuveen's 13F filing for Q2 2020, filed 14 Aug 2020.